ACRUX LIMITED — Investor Relations & Filings

Acrux Limited focuses on the development and commercialization of topical and transdermal drug delivery products. The company utilizes proprietary technology platforms to create a pipeline of generic and specialty pharmaceutical products, including creams, gels, ointments, and metered-dose sprays. It specializes in the formulation of complex topical medicines, leveraging expertise in skin penetration and drug delivery systems to improve patient compliance and therapeutic outcomes. The business model involves the internal development of products through to regulatory submission and subsequent commercialization via strategic partnerships. The company maintains a diverse portfolio targeting various therapeutic areas, with a significant emphasis on meeting regulatory requirements for international markets.